One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.
about
Utility of atherosclerosis imaging in the evaluation of high-density lipoprotein-raising therapies.Carotid intima-media thickness studies: study design and data analysis.Effect of nicotinic acid administration on hepatic very low density lipoprotein-triglyceride production.Smoking status and common carotid artery intima-medial thickness among middle-aged men and women based on ultrasound measurement: a cohort studyEpidemiology of cardiovascular disease in systemic lupus erythematosus.Postmenopausal hormone replacement therapy as antiatherosclerotic therapy.Effect of lower targets for blood pressure and LDL cholesterol on atherosclerosis in diabetes: the SANDS randomized trialTreatment of lipid disorders after stroke.Arterial remodeling associates with CKD progressionDoes nicotinic acid (niacin) lower blood pressure?What is the cardioprotective role of hormone replacement therapy?Multimodal cardiovascular magnetic resonance quantifies regional variation in vascular structure and function in patients with coronary artery disease: relationships with coronary disease severity.Identification and characterization of distinct C-terminal domains of the human hydroxycarboxylic acid receptor-2 that are essential for receptor export, constitutive activity, desensitization, and internalization.Self-reported menopausal symptoms, coronary artery calcification, and carotid intima-media thickness in recently menopausal women screened for the Kronos early estrogen prevention study (KEEPS)A practical protocol to measure common carotid artery intima-media thickness.Comparison of common carotid artery intima-media thickness between Brazilian Euro-descendants and Afro-descendants with atherosclerosis risk factorsNovel patent publications on high-affinity nicotinic acid receptor agonists.Acyl hydroxypyrazoles as novel agonists for high-affinity nicotinic acid receptor GPR109A: WO2008051403.Distinct kinetic and spatial patterns of protein kinase C (PKC)- and epidermal growth factor receptor (EGFR)-dependent activation of extracellular signal-regulated kinases 1 and 2 by human nicotinic acid receptor GPR109A.Arterial Stiffness and Chronic Kidney Disease.Effects of tibolone on blood flow resistance and intima-media thickness of the carotid arteries: effect of time since menopause.Risk factors for brain infarction in patients with Cushing's disease. Case reports.Long-term effects of LDL apheresis on carotid arterial atherosclerosis in familial hypercholesterolaemic patients.
P2860
Q30401532-653DE3D5-B21B-46DB-ACEA-B7FC9E9A4674Q30712446-4CBEF606-6B82-4648-9258-9E2050A2DDFAQ31919769-7B58598E-2A86-45EF-9838-33BABCDE3FF1Q33261670-7B03EB3F-1C0E-4480-8790-EB5E36A6DC4DQ33915424-9476421C-E7AA-4360-8E7B-55BECD5CC290Q34482151-1CFA7F03-078F-498D-8620-A39D122DC5B9Q34571157-80983E56-628B-4B10-98CD-93EA08CF5CABQ34674265-A0C51C53-2509-4F5A-AD35-B90E69084A56Q34870872-BBD50FE6-7DEB-41D2-8204-147DF3684848Q34894236-1957BE43-9FD4-42C9-A068-F86270CA42DFQ35058238-DC51598C-F4EB-4A29-914E-2E0D22CB56F3Q35666715-59AB8C6F-A6A3-4A09-8DDA-8C6BAF2ED30DQ36412846-8ECA54E2-5057-463E-B7E7-9D33A13828E5Q36736281-26BEB03D-9A91-4C2D-937F-B43240B86465Q37147113-13B6EDCE-2F86-482D-A025-268B21A0ECA4Q37261251-1578FCE3-59C8-4F2B-A516-2980E6770688Q37529810-FCB60CB1-88A0-4AFF-91C5-D8C5BB548E83Q37536057-4631666C-FC75-4E84-B0DE-56F3716D98B6Q38418432-212E6853-B3A4-44BF-B38C-601288E9C0A8Q38838192-6ED3A208-0E56-4C2E-A457-682D9802DB8AQ46905068-7D917C2E-2AC4-4319-9E7A-45031B2E6086Q48908588-C4782067-17E3-4CF1-ABD4-D5EEE720468FQ50650681-F1297829-CDD2-46AA-B24C-82CC7DF1253B
P2860
One-year reduction and longitudinal analysis of carotid intima-media thickness associated with colestipol/niacin therapy.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh-hant
name
One-year reduction and longitu ...... ith colestipol/niacin therapy.
@en
One-year reduction and longitu ...... ith colestipol/niacin therapy.
@nl
type
label
One-year reduction and longitu ...... ith colestipol/niacin therapy.
@en
One-year reduction and longitu ...... ith colestipol/niacin therapy.
@nl
prefLabel
One-year reduction and longitu ...... ith colestipol/niacin therapy.
@en
One-year reduction and longitu ...... ith colestipol/niacin therapy.
@nl
P2093
P1433
P1476
One-year reduction and longitu ...... ith colestipol/niacin therapy.
@en
P2093
D H Blankenhorn
D W Crawford
J K Erickson
R H Selzer
P304
P356
10.1161/01.STR.24.12.1779
P407
P577
1993-12-01T00:00:00Z